Hemostasis Market and Technologies

Topical hemostats and tissue sealants are assured of continued end-user interest due to their ability to improve the effectiveness of surgery and feasibility of minimally invasive surgery, as well as reduce complications and operating time. They also help prevent excess blood loss and aid reconstruction during surgical repair. However, these products are perennially locked in a battle for market dominance. While surgeons have shown a preference for topical hemostats for their lower costs, greater reliability, and established clinical record, there exist significant concerns regarding their use of animal source products.
The current total hemostat market size worldwide is 2B US$, 9% growth rate
–70 million surgical and procedure-based wounds annually worldwide
–20 million surgical procedures in the US
–“10-15% procedures would benefit from increased use of newly-developed adjunctive surgical closure and securement products”
The rising complexities of surgeries have triggered a simultaneous urgency for topical hemostats to control bleeding. These products are particularly useful in burn and wound care and a wide range of surgeries including cardiothoracic, neurosurgery, spine, orthopedic, vascular, dermatology/plastic, and many others. The increasing popularity of minimally invasive procedures is also boosting demand for topical hemostats, encouraging the development of niche products and application devices.

• Topical Hemostats:
  Collagen-based
  Oxygen regenerated cellulose-based
  Gelatin-based
  Thrombin-based
  Combination products
• Tissue Sealants:
  Fibrin
  Synthetic polymer-based
  Protein-based